非典型鳞状上皮细胞患者分流诊疗的研究进展
Research Progress of Shunt Diagnosis and Treatment in Patients with Atypical Squamous Epithelial Cells
摘要: 无明确意义的非典型鳞状上皮细胞(ASCUS)属于异常细胞范畴，其组织病理学具有不确定性和多样性，是临床中最常见也最难决定诊疗对策的细胞学检测结果。因ASCUS的特异度低，易发生诊断不足或过度诊断，故关于ASCUS患者的分流诊疗问题在临床中逐渐引起重视，并取得众多新进展。本文将从HPV基因分型、DNA定量分析、P16/Ki-67双染及PAX1甲基化在ASCUS患者分流诊疗中的临床价值入手，以期为ASCUS患者提供新的分流诊疗思路和选择。
Abstract: Atypical squamous cells of undetermined significance (ASCUS) belong to the category of abnormal cells. Its histopathology is uncertain and diverse, and it is the most common and difficult cytological test result to determine the diagnosis and treatment strategy in the clinic. Due to the low specificity of ASCUS, it is prone to underdiagnosis or overdiagnosis. Therefore, the problem of shunt diagnosis and treatment of ASCUS patients has gradually attracted attention in clinical practice, and much new progress has been made. This article will start with the clinical value of HPV genotyping, DNA quantitative analysis, P16/Ki-67 double staining and PAX1 methylation in the triage diagnosis and treatment of ASCUS patients, to provide new triage diagnosis and treatment ideas and choices for ASCUS patients.
文章引用：李阳, 徐颖, 刘培淑. 非典型鳞状上皮细胞患者分流诊疗的研究进展[J]. 临床医学进展, 2024, 14(5): 1205-1210. https://doi.org/10.12677/acm.2024.1451542

参考文献

[1] 中国抗癌协会妇科肿瘤专业委员会. 子宫颈癌诊断与治疗指南(2021年版) [J]. 中国癌症杂志, 2021, 31(6): 474-489.
[2] Nayar, R. and Solomon, D. (2004) Second Edition of ‘The Bethesda System for Reporting Cervical Cytology’ Atlas, Website, and Bethesda Interobserver Reproducibility Project. CytoJournal, 1, Article 4. [Google Scholar] [CrossRef] [PubMed]
[3] Possati-Resende, J.C., Fregnani, J., Kerr, L.M., et al. (2015) The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL. PLOS ONE, 10, e0134445. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, Z., Gu, Y., Wang, H., et al. (2020) Distribution of Cervical Lesions in High-Risk HPV (hr-HPV) Positive Women with ASC-US: A Retrospective Single-Center Study in China. Virology Journal, 17, Article No. 185. [Google Scholar] [CrossRef] [PubMed]
[5] 黄太胜, 候丛哲, 朱琳, 等. PAX1甲基化检测在非典型鳞状细胞分流中的临床应用研究[J]. 中国实用妇科与产科杂志, 2022, 38(8): 847-850.
[6] Schiffman, M., Vaughan, L.M., Raine-Bennett, T.R., et al. (2015) A Study of HPV Typing for the Management of HPV-Positive ASC-US Cervical Cytologic Results. Gynecologic Oncology, 183, 573-578. [Google Scholar] [CrossRef] [PubMed]
[7] Tao, X., Austin, R.M., Yu, T., et al. (2022) Risk Stratification for Cervical Neoplasia Using Extended High-Risk HPV Genotyping in Women with ASC-US Cytology: A Large Retrospective Study from China. Cancer Cytopathology, 130, 248-258. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, W., Zhang, H., Lin, L., et al. (2021) Efficient Combination of Human Papillomavirus Genotyping for the Triage of Women with Atypical Squamous Cells of Undetermined Significance in Chinese Rural Population: A Population-Based Study. Journal of Cancer, 12, 2815-2824. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, J., Cheng, K. and Wang, Z. (2020) Prevalence and Distribution of Human Papillomavirus Genotypes in Cervical Intraepithelial Neoplasia in China: A Meta-Analysis. Archives of Gynecology and Obstetrics, 302, 1329-1337. [Google Scholar] [CrossRef] [PubMed]
[10] Petry, K.U., Liebrich, C., Luyten, A., et al. (2017) Surgical Staging Identified False HPV-Negative Cases in a Large Series of Invasive Cervical Cancers. Papillomavirus Research, 4, 85-89. [Google Scholar] [CrossRef] [PubMed]
[11] 效小莉, 付凤仙, 宋紫晖, 等. 高危型HPV分型检测作为ASCUS分流管理手段的探讨[J]. 中国妇幼保健, 2019, 34(13): 2946-2949.
[12] 吴玉梅, 王建东, 张师前, 等. 老年女性子宫颈病变筛查及异常管理中国专家共识(2023年版) [J]. 中国实用妇科与产科杂志, 2023, 39(5): 531-536.
[13] 李小芳, 姜汉国, 陈永华, 等. DNA定量分析及HPV检测在意义不明的非典型鳞状细胞患者分流中的意义[J]. 广东医学院学报, 2015, 33(5): 558-561.
[14] 张敦兰, 阳艳, 周利敏. DNA倍体分析在ASCUS分流诊断中的意义[J]. 中华妇产科杂志, 2012, 47(4): 259-262.
[15] 潘银燕, 李世宏, 苏士忠, 等. 液基细胞学、HPV检测及DNA倍体定量分析在宫颈癌筛查中的价值[J]. 中国妇产科临床杂志, 2023, 24(1): 69-70.
[16] 马希, 郝敏. p16、Ki67及FRα预测低度宫颈上皮内瘤变转归的研究进展[J]. 现代肿瘤医学, 2020, 28(12): 2168-2172.
[17] Yu, L., Fei, L., Liu, X., et al. (2019) Application of p16/Ki-67 Dual-Staining Cytology in Cervical Cancers. Journal of Cancer, 10, 2654-2660. [Google Scholar] [CrossRef] [PubMed]
[18] Han, Q., Guo, H., Geng, L., et al. (2020) p16/Ki-67 Dual-Stained Cytology Used for Triage in Cervical Cancer Opportunistic Screening. Chinese Journal of Cancer Research, 32, 208-217. [Google Scholar] [CrossRef] [PubMed]
[19] Uijterwaal, M.H., Witte, B.I., Van Kemenade, F.J., et al. (2014) Triaging Borderline/Mild Dyskaryotic Pap Cytology with p16/Ki-67 Dual-Stained Cytology Testing: Cross-Sectional and Longitudinal Outcome Study. British Journal of Cancer, 110, 1579-1586. [Google Scholar] [CrossRef] [PubMed]
[20] Wentzensen, N., Fetterman, B., Castle, P.E., et al. (2015) p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. Journal of the National Cancer Institute, 107, 257-265. [Google Scholar] [CrossRef] [PubMed]
[21] Dawson, M.A. and Kouzarides, T. (2012) Cancer Epigenetics: From Mechanism to Therapy. Cell, 150, 12-27. [Google Scholar] [CrossRef] [PubMed]
[22] Thompson, B., Davidson, E.A., Liu, W., et al. (2021) Overview of PAX Gene Family: Analysis of Human Tissue-Specific Variant Expression and Involvement in Human Disease. Human Genetics, 140, 381-400. [Google Scholar] [CrossRef] [PubMed]
[23] Pun, P.B., Liao, Y.-P., Su, P.-H., et al. (2015) Triage of High-Risk Human Papillomavirus-Positive Women by Methylated POU4F3. Clinical Epigenetics, 7, 85-93. [Google Scholar] [CrossRef] [PubMed]
[24] 梁婷婷, 王华丽, 朱琳, 等. PAX1基因甲基化与宫颈高级别上皮内病变及高危型HPV分型的关联性[J]. 山东大学学报, 2015, 59(11): 48-52.
[25] Liu, H., Meng, X. and Wang, J. (2020) Real Time Quantitative Methylation Detection of PAX1 Gene in Cervical Cancer Screening. International Journal of Gynecological Cancer, 30, 1488-1492. [Google Scholar] [CrossRef] [PubMed]
[26] Li, S.R., Wang, Z.M., Wang, Y.H., et al. (2015) Value of PAX1 Methylation Analysis by MS-HRM in the Triage of Atypical Squamous Cells of Undetermined Significance. Asian Pacific Journal of Cancer Prevention, 16, 5843-5846. [Google Scholar] [CrossRef] 

为你推荐